-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on LivaNova, Raises Price Target to $90

Benzinga·09/02/2026 16:33:57
Listen to the news
Piper Sandler analyst Adam Maeder reiterates LivaNova (NASDAQ:LIVN) with a Overweight and raises the price target from $87 to $90.